Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sirnaomics Ltd. ( (HK:2257) ) has shared an update.
Sirnaomics Ltd. has announced the completion of its remedial actions to address internal control weaknesses and deficiencies, as identified in a recent internal control review. The company engaged PAL Advisory Limited to assess the effectiveness of these actions, particularly focusing on business communication standards. The review confirmed that the company’s measures, including mandatory training and policy updates, have adequately addressed the issues, thereby enhancing data security and compliance within the organization.
The most recent analyst rating on (HK:2257) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Sirnaomics Ltd. stock, see the HK:2257 Stock Forecast page.
More about Sirnaomics Ltd.
Sirnaomics Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on developing RNAi therapeutics, which are designed to treat various diseases by silencing specific genes.
Average Trading Volume: 1,123,169
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.02B
See more insights into 2257 stock on TipRanks’ Stock Analysis page.